Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2018-07-10 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-VALERIEN (89150), Yonne
PHARMACIE DU GATINAIS : revenue, balance sheet and financial ratios
PHARMACIE DU GATINAIS is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-VALERIEN (89150),
this company of category PME
shows in 2024 a revenue of 2.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU GATINAIS (SIREN 840971956)
Indicator
2025
2024
2023
2022
2021
2020
2019
Revenue
N/C
2 644 887 €
2 749 055 €
2 585 370 €
2 464 658 €
2 301 595 €
1 755 677 €
Net income
118 877 €
147 669 €
139 186 €
206 274 €
189 001 €
172 474 €
62 111 €
EBITDA
N/C
228 165 €
219 710 €
327 425 €
297 964 €
273 310 €
110 320 €
Net margin
N/C
5.6%
5.1%
8.0%
7.7%
7.5%
3.5%
Revenue and income statement
In 2025, PHARMACIE DU GATINAIS generates positive net income of 119 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 62 k€ -> 119 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
118 877 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 113%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 43%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
113.273%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
42.676%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU GATINAIS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Debt ratio
2637.193
935.827
499.427
309.615
221.435
156.819
113.273
Financial autonomy
3.209
8.737
15.186
22.459
27.659
36.01
42.676
Repayment capacity
30.206
13.28
11.383
9.277
11.944
9.217
None
Cash flow / Revenue
3.586%
7.56%
7.761%
8.291%
5.27%
5.981%
None%
Sector positioning
Debt ratio
113.272025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
In 2025, the debt ratio of PHARMACIE DU GATINAIS (113.27) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
42.68%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average+11 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DU GATINAIS (42.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
9.22 years2024
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Watch
In 2024, the repayment capacity of PHARMACIE DU GATINAIS (9.22) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 148.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
148.881
Liquidity indicators evolution PHARMACIE DU GATINAIS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
117.85
336.797
367.32
311.537
216.914
225.649
148.881
Interest coverage
18.37
10.221
9.749
9.501
12.476
10.316
None
Sector positioning
Liquidity ratio
148.882025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average-25 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DU GATINAIS (148.88) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
10.32x2024
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Excellent
In 2024, the interest coverage of PHARMACIE DU GATINAIS (10.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU GATINAIS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Operating WCR
-102 777 €
42 464 €
90 256 €
136 766 €
161 782 €
107 303 €
0 €
Inventory turnover (days)
23
16
15
20
17
11
0
Customer payment term (days)
7
4
4
4
5
6
0
Supplier payment term (days)
0
37
41
36
47
27
0
Positioning of PHARMACIE DU GATINAIS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU GATINAIS is estimated at
1 888 375 €
(range 1 281 460€ - 2 963 120€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1281k€1888k€2963k€
1 888 375 €Range: 1 281 460€ - 2 963 120€
NAF 5 année 2025
Valuation method used
Net Income Multiple
118 877 €
×
15.9x
=1 888 375 €
Range: 1 281 460€ - 2 963 121€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU GATINAIS with other companies in the same sector:
Frequently asked questions about PHARMACIE DU GATINAIS
What is the revenue of PHARMACIE DU GATINAIS ?
The revenue of PHARMACIE DU GATINAIS in 2024 is 2.6 M€.
Is PHARMACIE DU GATINAIS profitable?
Yes, PHARMACIE DU GATINAIS generated a net profit of 119 k€ in 2025.
Where is the headquarters of PHARMACIE DU GATINAIS ?
The headquarters of PHARMACIE DU GATINAIS is located in SAINT-VALERIEN (89150), in the department Yonne.
Where to find the tax return of PHARMACIE DU GATINAIS ?
The tax return of PHARMACIE DU GATINAIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU GATINAIS operate?
PHARMACIE DU GATINAIS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart